Cite
MLA Citation
Paul Emery et al.. “264 Secukinumab demonstrates low radiographic progression and sustained efficacy through 4 years in patients with active ankylosing spondylitis.” Rheumatology, vol. 58, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100094063505.0x000015